HomeInsightsStock Comparison

Anuh Pharma Ltd vs Bliss Gvs Pharma Ltd Stock Comparison

Anuh Pharma Ltd vs Bliss Gvs Pharma Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Anuh Pharma Ltd is ₹ 95.66 as of 01 Aug 15:30.
  • The P/E Ratio of Anuh Pharma Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Bliss GVS Pharma Ltd changed from 10.7 on March 2020 to 14.7 on March 2025 . This represents a CAGR of 5.44% over 6 years.
  • The Market Cap of Anuh Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1039 crore on March 2020 to ₹ 1238 crore on March 2025 . This represents a CAGR of 2.96% over 6 years.
  • The revenue of Anuh Pharma Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bliss GVS Pharma Ltd for the Jun '25 is ₹ 242.92 crore as compare to the Mar '25 revenue of ₹ 210.05 crore. This represent the growth of 15.65%.
  • The ebitda of Anuh Pharma Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Bliss GVS Pharma Ltd for the Jun '25 is ₹ 76.78 crore as compare to the Mar '25 ebitda of ₹ 33.15 crore. This represent the growth of 131.61%.
  • The net profit of Anuh Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Bliss GVS Pharma Ltd changed from ₹ 14.37 crore to ₹ 44.36 crore over 9 quarters. This represents a CAGR of 65.03% .
  • The Dividend Payout of Anuh Pharma Ltd changed from 60.03 % on March 2020 to 15.88 % on March 2025 . This represents a CAGR of -19.88% over 6 yearsThe Dividend Payout of Bliss GVS Pharma Ltd changed from 5.58 % on March 2020 to 7.64 % on March 2025 . This represents a CAGR of 5.38% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Anuh Pharma Ltd

  • Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs).
  • The Company is engaged in the business of manufacturing and selling of 'Bulk drugs and chemicals.
  • The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals.
  • It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra. The Company was incorporated on February 19, 1960.
  • The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra.

About Bliss GVS Pharma Ltd

  • Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
  • The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
  • The Company has its manufacturing facility at Palghar which is WHO GMP approved.
  • The business operates five cutting-edge production facilities that adhere to WHO-GMP, EU-MP, ISO 14001 and OHSAS 45001 standards. The company commenced its business in 1985.
  • In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharma's R&D center, received approval from Government of India's Department for Scientific & Industrial Research (DSIR).

Anuh Pharma Ltd News Hub

News

Anuh Pharma to discuss results

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 8 August 2025....

Read more

02 Aug 2025 11:03

News

Board of Anuh Pharma allots 5.01 lakh bonus equity shares

The Board of Anuh Pharma at its meeting held on 16 July 2025 has allotted 5,01,12,000 full...

Read more

16 Jul 2025 19:39

News

Anuh Pharma gains after inaugurating new manufacturing block in Maharashtra

In a regulatory filing, the company stated that the new facility is expected to become ope...

Read more

15 Jul 2025 15:10

News

Anuh Pharma schedules AGM

Anuh Pharma announced that the 65th Annual General Meeting(AGM) of the company will be hel...

Read more

24 May 2025 17:31

News

Board of Anuh Pharma recommends final dividend

Anuh Pharma announced that the Board of Directors of the Company at its meeting held on 23...

Read more

24 May 2025 11:49

News

Anuh Pharma to table results

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 23 May 2025. P...

Read more

20 May 2025 15:35

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma Ltd leads gainers in 'B' group

Foseco India Ltd, Saurashtra Cement Ltd, Omax Autos Ltd and Manaksia Aluminium Company Ltd...

Read more

30 Jul 2025 12:15

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 29 July 2...

Read more

23 Jul 2025 09:49

News

Bliss GVS Pharma Ltd leads gainers in 'B' group

Northern ARC Capital Ltd, Apollo Micro Systems Ltd, IRM Energy Ltd and Malu Paper Mills Lt...

Read more

23 Jun 2025 12:15

News

Bliss GVS Pharma allots 75,250 equity shares under ESOP

Bliss GVS Pharma has allotted 75,250 equity shares under ESOP on 06 June 2025. Consequentl...

Read more

06 Jun 2025 13:51

News

Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held ...

Read more

13 May 2025 09:26

News

Bliss GVS Pharma schedules AGM

Bliss GVS Pharma announced that the 40th Annual General Meeting(AGM) of the company will b...

Read more

13 May 2025 12:51

SWOT Analysis Of Anuh Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Anuh Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Bliss GVS Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Anuh Pharma Ltd and Bliss GVS Pharma Ltd

Which company has a larger market capitalization, Anuh Pharma Ltd or Bliss GVS Pharma Ltd?

Market cap of Anuh Pharma Ltd is 958 Cr while Market cap of Bliss GVS Pharma Ltd is 1,832 Cr

What are the key factors driving the stock performance of Anuh Pharma Ltd and Bliss GVS Pharma Ltd?

The stock performance of Anuh Pharma Ltd and Bliss GVS Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anuh Pharma Ltd and Bliss GVS Pharma Ltd?

As of August 2, 2025, the Anuh Pharma Ltd stock price is INR ₹95.66. On the other hand, Bliss GVS Pharma Ltd stock price is INR ₹173.7.

How do dividend payouts of Anuh Pharma Ltd and Bliss GVS Pharma Ltd compare?

To compare the dividend payouts of Anuh Pharma Ltd and Bliss GVS Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions